Show simple item record

dc.contributor.author
Geissler, Julia
dc.contributor.author
Jans, Thomas
dc.contributor.author
Banaschewski, Tobias
dc.contributor.author
Becker, Katja
dc.contributor.author
Renner, Tobias
dc.contributor.author
Brandeis, Daniel
dc.contributor.author
Doepfner, Manfred
dc.contributor.author
Dose, Christina
dc.contributor.author
Hautmann, Christopher
dc.contributor.author
Holtmann, Martin
dc.contributor.author
Jenkner, Carolin
dc.contributor.author
Millenet, Sabina
dc.contributor.author
Romanos, Marcel
dc.date.accessioned
2018-05-30T12:53:09Z
dc.date.available
2018-05-18T17:30:18Z
dc.date.available
2018-05-30T12:53:09Z
dc.date.issued
2018-04-27
dc.identifier.issn
1468-6694
dc.identifier.issn
1745-6215
dc.identifier.issn
1468-6708
dc.identifier.other
10.1186/s13063-018-2635-2
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/265171
dc.identifier.doi
10.3929/ethz-b-000265171
dc.description.abstract
Background: Despite the high persistence rate of attention-deficit/hyperactivity disorder (ADHD) throughout the lifespan, there is a considerable gap in knowledge regarding effective treatment strategies for adolescents with ADHD. This group in particular often shows substantial psychosocial impairment, low compliance and insufficient response to psychopharmacological interventions. Effective and feasible treatments should further consider the developmental shift in ADHD symptoms, comorbidity and psychosocial adversity as well as family dysfunction. Thus, individualised interventions for adolescent ADHD should comprise a multimodal treatment strategy. The randomised controlled ESCAadol study addresses the needs of this patient group and compares the outcome of short-term cognitive behavioural therapy with parent-based telephone-assisted self-help. Methods/design: In step 1, 160 adolescents aged 12 to 17 years with a diagnosis of ADHD will undergo a treatment as usual (TAU) observation phase of 1 month. In step 2, those still severely affected are randomised to the intervention group with an Individualised Modular Treatment Programme (IMTP) or a telephone-assisted self-help programme for parents (TASH) as an active control condition. The IMTP was specifically designed for the needs of adolescent ADHD. It comprises 10 sessions of individual cognitive behavioural therapy with the adolescents and/or the parents, for which participants choose three out of 10 available focus modules (e.g. organisational skills and planning, emotion regulation, problem solving and stress management, dysfunctional family communication). TASH combines a bibliotherapeutic component with 10 counselling sessions for the parents via telephone. Primary outcome is the change in ADHD symptoms in a clinician-rated diagnostic interview. Outcomes are assessed at inclusion into the study, after the TAU phase, after the intervention phase and after a further 12-week follow-up period. The primary statistical analysis will be by intention-to-treat, using linear regression models. Additionally, we will analyse psychometric and biological predictors and moderators of treatment response. Discussion: ESCAadol compares two short-term non-pharmacological interventions as cost-efficient and feasible treatment options for adolescent ADHD, addressing the specific needs and obstacles to treatment success in this group. We aim to contribute to personalised medicine for adolescent ADHD intended to be implemented in routine clinical care.
en_US
dc.format
application/pdf
en_US
dc.language.iso
en
en_US
dc.publisher
BioMed Central
en_US
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Attention-deficit/hyperactivity disorder
en_US
dc.subject
ADHD
en_US
dc.subject
Adolescents
en_US
dc.subject
Behaviour therapy
en_US
dc.subject
Individualised modular treatment programme
en_US
dc.subject
Telephone-assisted self-help
en_US
dc.subject
RCT
en_US
dc.title
Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife
en_US
dc.type
Journal Article
dc.rights.license
Creative Commons Attribution 4.0 International
ethz.journal.title
Trials
ethz.journal.volume
19
en_US
ethz.pages.start
254
en_US
ethz.size
16 p.
en_US
ethz.version.deposit
publishedVersion
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
London
en_US
ethz.publication.status
published
en_US
ethz.date.deposited
2018-05-18T17:31:11Z
ethz.source
WOS
ethz.eth
yes
en_US
ethz.availability
Open access
en_US
ethz.rosetta.installDate
2018-05-30T12:53:15Z
ethz.rosetta.lastUpdated
2022-03-28T20:17:47Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Individualised%20short-term%20therapy%20for%20adolescents%20impaired%20by%20attention-deficit/hyperactivity%20disorder%20despite%20previous%20routine%20care%20treatment%&rft.jtitle=Trials&rft.date=2018-04-27&rft.volume=19&rft.spage=254&rft.issn=1468-6694&1745-6215&1468-6708&rft.au=Geissler,%20Julia&Jans,%20Thomas&Banaschewski,%20Tobias&Becker,%20Katja&Renner,%20Tobias&rft.genre=article&rft_id=info:doi/10.1186/s13063-018-2635-2&
 Search print copy at ETH Library

Files in this item

Thumbnail

Publication type

Show simple item record